Form 8-K - Current report:
SEC Accession No. 0001104659-26-086254
Filing Date
2026-07-23
Accepted
2026-07-23 16:05:20
Documents
11
Period of Report
2026-07-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2621205d1_8k.htm   iXBRL 8-K 26444
  Complete submission text file 0001104659-26-086254.txt   189004

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA apre-20260723.xsd EX-101.SCH 3005
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE apre-20260723_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apre-20260723_pre.xml EX-101.PRE 22352
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2621205d1_8k_htm.xml XML 3095
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 215-948-4119
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 261197045
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)